Novo Nordisk purchases B shares worth DKK 5.428B from Novo Holdings A/S

Novo Nordisk A/S has entered into an agreement to purchase 6,311,250 B shares of DKK 0.10 at a value of DKK 5.427,801,225B from Novo Holdings A/S as part of Novo Nordisk A/S’ 2024 share repurchase programme of up to a total of DKK 20B to be executed during a 12-month period beginning February 6. The transaction price is DKK 860.02 per share and has been calculated as the three-day volume weighted average market price from May 2 to May 6 in the open window following the announcement of Novo Nordisk A/S’ quarterly financial results, the company stated.